Generic of Gilead’s HIV pre-exposure drug coming to market in 2020

09-05-2019

Generic of Gilead’s HIV pre-exposure drug coming to market in 2020

eyesonmilan / Shutterstock.com

A generic version of Gilead’s Truvada (emtricitabine/tenofovir disoproxil fumarate) will hit the market in 2020, a year earlier than expected.


Gilead, PrEP, HIV, Truvada, generics, Teva, CDC, innovation, PrEP4All, break the patent

LSIPR